The development, manufacturing, and commercialization of technologies, bioinks, biomaterials, bioprinters, and related services for creating functional, vascularized biological organ constructs (like kidneys, livers, hearts, and lungs) with additive manufacturing processes are all included in the 3D bioprinted organ transplants market. To recreate native tissue architecture and physiology, these constructions are made from patient-specific or biobank-sourced cells, stacked with growth factors and supported by hydrogels. The primary demand driver for the development of bioprinted organs is the ongoing paucity of organ donors, with over 100,000 patients on transplant waiting lists in the US alone